19th International Symposium on Epstein–Barr Virus and Associated Diseases, 29–30 July 2021, Asahikawa, Japan

Takumi Kumai; Miki Takahara; Yasuaki Harabuchi

doi:10.3390/cancers14122924

Cancers (Jun 2022)

19th International Symposium on Epstein–Barr Virus and Associated Diseases, 29–30 July 2021, Asahikawa, Japan

Takumi Kumai,
Miki Takahara,
Yasuaki Harabuchi

Affiliations

Takumi Kumai: Department of Innovative Head and Neck Cancer Research and Treatment, Asahikawa Medical University, Asahikawa 078-8510, Japan
Miki Takahara: Department of Otolaryngology-Head and Neck Surgery, Asahikawa Medical University, Asahikawa 078-8510, Japan
Yasuaki Harabuchi: Department of Otolaryngology-Head and Neck Surgery, Asahikawa Medical University, Asahikawa 078-8510, Japan

DOI: https://doi.org/10.3390/cancers14122924
Journal volume & issue: Vol. 14, no. 12
p. 2924

Abstract

Read online

Novel insights into Epstein–Barr virus (EBV) pathogenicity were presented at the “19th International Symposium on Epstein-Barr Virus and Associated Diseases” in Asahikawa, Japan. In addition, basic and translational findings on EBV-associated tumors, including natural killer (NK)/T-cell lymphoma, gastric cancer, and nasopharyngeal cancer, were presented by an international group of scientists and clinicians.

Published in Cancers

ISSN: 2072-6694 (Online)
Publisher: MDPI AG
Country of publisher: Switzerland
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://www.mdpi.com/journal/cancers/

About the journal

Abstract

Keywords